Myelomastocytic leukemia versus mast cell leukemia versus systemic mastocytosis associated with acute myeloid leukemia: A diagnostic challenge

American Journal of Hematology

Volumn 85, Issue 8, 2010, Pages 600-606

  Arredondo, Angela R ^a   Gotlib, Jason ^a   Shier, Luke ^b   Medeiros, Bruno ^a   Wong, Kathleen ^b   Cherry, Athena ^a   Corless, Christopher ^c   Arber, Daniel A ^a   Valent, Peter ^d   George, Tracy I ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CLADRIBINE; CLOFARABINE; CYTARABINE; DASATINIB; DAUNORUBICIN; ZOSUQUIDAR;

ABDOMINAL PAIN; ABDOMINAL RADIOGRAPHY; ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; CELL STRUCTURE; CLINICAL TRIAL; CYTOGENETICS; FATIGUE; FEMALE; HEPATOMEGALY; HUMAN; LABORATORY TEST; LEUKEMIA; MALE; MAST CELL LEUKEMIA; MULTIPLE CYCLE TREATMENT; MYELOMASTOCYTIC LEUKEMIA; MYELOPOIESIS; NAUSEA AND VOMITING; PETECHIA; PRIORITY JOURNAL; RARE DISEASE; STEM CELL TRANSPLANTATION; SYSTEMIC MASTOCYTOSIS; URTICARIA; BLOOD; BONE MARROW; CANCER STEM CELL; CELL CLONE; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; FATALITY; GENETICS; INFECTION; KARYOTYPING; MAST CELL; MIDDLE AGED; MYELODYSPLASTIC SYNDROME; MYELOID LEUKEMIA; PATHOLOGY; REVIEW; STAINING;

ADULT; BONE MARROW; CLONE CELLS; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC ERRORS; DISEASE PROGRESSION; FATAL OUTCOME; FEMALE; HUMANS; INFECTION; KARYOTYPING; LEUKEMIA, MAST-CELL; LEUKEMIA, MYELOID; MALE; MAST CELLS; MASTOCYTOSIS, SYSTEMIC; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; MYELOPOIESIS; NEOPLASTIC STEM CELLS; STAINING AND LABELING; URTICARIA;

EID: 77955483681     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21713     Document Type: Article

References (28)

1. Horny HP, Akin C, Metcalfe DD, et al. Mastocytosis. In: Swerdlow S, Campo E, Lee Harris N, et al., editors. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press; 2008. pp 53-63.
2. Valent P, Sperr WR, Schwartz LB, Horny HP. Diagnosis and classification of mast cell proliferative disorders: Delineation from immunologic diseases and non-mast cell hematopoietic neoplasms. J Allergy Clin Immunol 2004;114:3-11. (Pubitemid 39005111)
3. Valent P, Samorapoompichit P, Sperr WR, et al. Myelomastocytic leukemia: Myeloid neoplasm characterized by partial differentiation of mast cell-lineage cells. Hematol J 2002;3:90-94. (Pubitemid 34555535)
4. Valent P, Horny HP, Escribano L, et al. Diagnostic criteria and classification of mastocytosis: A consensus proposal. Leuk Res 2001;25:603-625.
5. Sperr WR, Escribano L, Jordan JH, et al. Morphologic properties of mast cells: Delineation of stages of maturation and implication for cytological grading of mastocytosis. Leuk Res 2001;25:529-536. (Pubitemid 32506759)
6. Horny HP, Sotlar K, Valent P. Mastocytosis: State of the art. Pathobiology 2007;74:121-132.
7. Corless CL, Harrell P, Lacouture M, et al. Allele-specific polymerase chain reaction for the imatinib-resistant KIT D816V and D816F mutations in mastocytosis and acute myelogenous leukemia. J Mol Diagn 2006;8:604-612. (Pubitemid 44774160)
8. Valent P, Sperr WR, Samorapoompichit P, et al. Myelomastocytic overlap syndromes: Biology, criteria, and relationship to mastocytosis. Leuk Res 2001;25:595-602. (Pubitemid 32506767)
9. Sperr WR, Drach J, Hauswirth AW, et al. Myelomastocytic leukemia: Evidence for the origin of mast cells from the leukemic clone and eradication by allogeneic stem cell transplantation. Clin Cancer Res 2005;11:6787-6792. (Pubitemid 41428732)
10. Wimazal F, Sperr WR, Horny HP, et al. Hyperfibrinolysis in a case of myelodysplastic syndrome with leukemic spread of mast cells. Am J Hematol 1999;61:66-77.
11. Samorapoompichit P, Schernthaner GH, Worda C, et al. Evaluation of neoplastic human mast cells by tryptase-immunoelectron microscopy. Histopathology 2006;48:247-257.
12. Valent P, Spanblochl E, Bankl HC, et al. Kit ligand/mast cell growth factor- independent differentiation of mast cells in myelodysplasia and chronic myeloid leukemic blast crisis. Blood 1994;84:4322-4332. (Pubitemid 24371939)
13. Paschka P, Marucci G, Ruppert AS, et al. Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): A cancer and leukemia group B study. J Clin Oncol 2006;24:3904-3911. (Pubitemid 46630738)
14. Sperr WR, Horny HP, Lechner K, Valent P. Clinical and biological diversity of leukemias occurring in patients with mastocytosis. Leuk Lymphoma 2000;37:473-486. (Pubitemid 30219056)
15. Sperr WR, Walchshofer S, Horny HP, et al. Systemic mastocytosis associated with acute myeloid leukemia: Report of two cases and detection of the c-kit mutation Asp-816 to Val. Br J Haematol 1998;103:740-749.
16. Dash A, Gilliland DG. Molecular genetics of acute myeloid leukemia. Best Pract Res Clin Hematol 2001;14:49-64. (Pubitemid 32372401)
17. Escribano L, Garcia-Montero A, Nuñez-López R, et al. Systemic mastocytosis associated acute myeloid leukemia: Case report and implications for disease pathogenesis. J Allergy Clin Immunol 2004;114:28-33. (Pubitemid 39005115)
18. Bernd HW, Sotlar K, Lorenzen J, et al. Acute myeloid leukaemia with t(8;21) associated with "occult" mastocytosis. Report of an unusual case and review of the literature. J Clin Pathol 2004;57:324-328.
19. Pullarkat V, Bedell V, Kim Y, et al. Neoplastic mast cells in systemic mastocytosis associated with t(8;21) acute myeloid leukemia are derived from the leukemic clone. Leuk Res 2007;31:261-265. (Pubitemid 44854181)
20. Wong KF, Chan JKC, Chan JCW, et al. Concurrent acute myeloid leukemia and systemic mastocytosis. Am J Hematol 1991;42:410-411.
21. Nagai S, Ichikawa M, Takahashi T, et al. The origin of neoplastic mast cells in systemic mastocytosis with AML1/ETO positive acute myeloid leukemia. Exp Hematol 2007;35:1747-1752. (Pubitemid 47633774)
22. Sotlar K, Fridrich C, Mall A, et al. Detection of c-kit point mutation Asp-816 ? Val in microdissected pooled single mast cells and leukemic cells in a patient with systemic mastocytosis and concomitant chronic myelomonocytic leukemia. Leuk Res 2002;26:979-984. (Pubitemid 35287206)
23. Ustun C, Corless CL, Savage N, et al. Chemotherapy and dasatinib induce long-term hematologic and molecular remission in systemic mastocytosis with acute myeloid leukemia with KIT D816V. Leuk Res 2009;33:735-741.
24. Noack F, Sotlar K, Notter M, et al. Aleukemic mast cell leukemia with abnormal immunophenotype and c-kit mutation D816V. Leuk Lymphoma 2004;45:2295-2302.
25. Valentini CG, Rondoni M, Pogliani EM, et al. Mast cell leukemia: A report of ten cases. Ann Hematol 2008;87:505-508.
26. Gotlib J, Berube C, Growney JD, et al. Activity of tyrosine kinase inhibitor PK412 in a patient with mast cell leukemia with the D816V KIT mutation. Blood 2005;106:2865-2870.
27. Gotlib J, George TI, Corless C, et al. The KIT tyrosine kinase inhibitor midostaurine (PKC412) exhibits a high response rate in aggressive systemic mastocytosis (ASM): Interim results of a phase II trial. Blood (ASH Annu Meet Abstr) 2007;110:3536.
28. Verstovsek S, Tefferi A, Cortes J, et al. Phase II study of dasatinib in Philadelphia chromosome-negative acute and chronic myeloid diseases, including systemic mastocytosis. Clin Cancer Res 2008;14:3906-3915.